Biocair, a leading specialist in cell and gene therapy logistics, is proud to announce its alliance with Pharma.Aero, a global cross-industry collaboration platform. Together, they are driving transformation in the cell and gene therapy (CGT) supply chain.
Cell and gene therapies are a revolutionary way to fight disease in that they offer patients complete personalization of medicine. These time-sensitive and life-changing medicines need logistics solutions as innovative as they are.
Source Genomics White Paper explores the transformative power of multi-omics in genomic research.
Multiomics combines the various ‘omics disciplines that make up the complex landscape of life science research. With the integration of genomic, transcriptomic, proteomic and epigenomic data, we obtain an advanced vision of the overarching framework behind all phenotypic outcomes.
AMSBIO has announced a new range of customizable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results.
With over 500 ELISA kits to choose from, the new range covers a wide variety of biological processes, targets, and sample types. Reagents such as matched antibody pairs and a micro-ELISA pre-plate have been carefully screened and validated to save you time and money.
Entire 11,000 sq ft next generation lab developed by Gen Two to become the British biotech company’s HQ
LONDON, 23 NOVEMBER 2023 – Constructive Bio
Innovate UK, a division of UK Research and Innovation, is offering an investment opportunity of up to £10 million for pioneering projects in advancing cancer immunotherapies and paediatric cancer treatments.
Projects may focus on:
Arise Innovation Hubs, part of Anglia Ruskin University (ARU), has launched a new grant programme. Arise ABOVE (Arise Beyond Open Innovation for Value and Entrepreneurship) will deliver innovation grants, expert support and events to unlock HealthTech and MedTech investment in Essex.
OXFORD, UK – 22 November 2023 – PrecisionLife®, a leading computational biology company focused on precision medicine in complex chronic diseases, announces the appointment of Dr Gerald Dunstan as SVP Corporate Development and Hannah Bibby as Product Strategy Lead to drive the company’s expansion into precision diagnostics and personalized healthcare.
Following a period of sustained growth, life science logistics company Biocair has relocated and expanded its Chicago office and warehouse facility. As part of its wider global growth strategy, the leading specialist has increased its 2,904 sq. ft. space by more than double, securing a new 7,213 sq. ft. facility just three miles from the key cargo complex at O’Hare International Airport.
New 60,000 sq ft multi-occupancy building will provide additional space for life science companies within Cambridge cluster